-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Eli Lilly, Raises Price Target to $1425

Benzinga·07/13/2026 18:25:43
Listen to the news
UBS analyst Michael Yee maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1250 to $1425.